These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7074656)

  • 1. Prognostic significance of mediastinal mass in childhood Hodgkin's disease.
    Roskos RR; Evans RC; Gilchrist GS; Burgert EO; Ilstrup DM
    Cancer Treat Rep; 1982 Apr; 66(4):961-8. PubMed ID: 7074656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence of age on treatment results in children and adolescents with Hodgkin's disease].
    Balwierz W; Moryl-Bujakowska A; Depowska T; Klekawka T; Stanuch H; Matysiak M; Sopyło B; Kołakowska-Mrozowska B; Krenke K; Chybicka A; Raś M; Sońta-Jakimczyk D; Moszant A; Wachowiak J; Kaczmarek-Kanold M; Kowalczyk J; Odój T; Balcerska A; Drozyńska E; Wysocki M; Kołtan A; Krawczuk-Rybak M; Stolarska M
    Przegl Lek; 2004; 61 Suppl 2():40-4. PubMed ID: 15686044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
    Mjaaland I; Ganser D; Freitag EM; Bohndorf W
    Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hodgkin's disease: a retrospective analysis of 15 years experience at a large referral centre.
    Chandi L; Kumar L; Kochupillai V; Dawar R; Singh R
    Natl Med J India; 1998; 11(5):212-7. PubMed ID: 10997167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients.
    Brice P; Bastion Y; Divine M; Nedellec G; Ferrant A; Gabarre J; Reman O; Lepage E; Fermé C
    Cancer; 1996 Sep; 78(6):1293-9. PubMed ID: 8826953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Does the residual mediastinal mass have prognostic significance in children with Hodgkin's disease (HD)?].
    Klekawka T; Balwierz W; Moryl-Bujakowska A; Stanuch H; Matysiak M; Rokicka-Milewska R; Sopyło B; Kołakowska-Mrozowska B; Krenke K; Chybicka A; Chaber R; Sońita-Jakimczyki D; Janik-Moszants A; Wachowiak J; Kaczmarek-Kanold M; Kowalczyk J; Odój T; Balcerska A; Adamkiewicz-Drozyińska E; Wysocki M; Koltan A; Krawczuk-Rybako M; Muszyńska-Rosłan K; Stolarska M
    Przegl Lek; 2006; 63(1):21-4. PubMed ID: 16892894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of mediastinal adenopathy on site and frequency of relapse in patients with Hodgkin's disease.
    Mauch P; Gorshein D; Cunningham J; Hellman S
    Cancer Treat Rep; 1982 Apr; 66(4):809-17. PubMed ID: 7074652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mediastinal involvement in Hodgkin's disease: prognostic factors and distribution of intrathoracic adenopathies.
    Cionini L; Villari N; Ponticelli P; Biti GP; Mungai V
    Eur J Radiol; 1982 Nov; 2(4):301-6. PubMed ID: 7151818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of Hodgkin's disease at diagnosis in young children.
    White L; McCourt BA; Isaacs H; Siegel SE; Stowe SM; Higgins GR
    Am J Pediatr Hematol Oncol; 1983; 5(3):251-7. PubMed ID: 6625107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of lung irradiation for Hodgkin's disease patient with large mediastinal masses and/or hilar disease.
    Lee CK; Bloomfield CD; Levitt SH
    Cancer Treat Rep; 1982 Apr; 66(4):819-25. PubMed ID: 7074653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of Hodgkin's disease with bulky mediastinal involvement. Study of 28 cases].
    Acín P; Besses C; Pedro C; Monzó S; Sans-Sabrafén J
    Rev Clin Esp; 1997 Nov; 197(11):752-6. PubMed ID: 9547194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second malignant tumours in childhood Hodgkin's disease.
    Jenkin D; Greenberg M; Fitzgerald A
    Med Pediatr Oncol; 1996 Jun; 26(6):373-9. PubMed ID: 8614372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benign mass lesions after therapy for Hodgkin's disease.
    Durkin W; Durant J
    Arch Intern Med; 1979 Mar; 139(3):333-6. PubMed ID: 426577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes.
    Wheeler C; Eickhoff C; Elias A; Ibrahim J; Ayash L; McCauley M; Mauch P; Schwartz G; Eder JP; Mazanet R; Ferrara J; Rimm IJ; Guinan E; Bierer B; Gilliland G; Churchill WH; Ault K; Parsons S; Antman K; Schnipper L; Tepler I; Gaynes L; Frei E; Kadin M; Antin J
    Biol Blood Marrow Transplant; 1997 Jun; 3(2):98-106. PubMed ID: 9267670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease.
    Glavina-Durdov M; Jakic-Razumovic J; Capkun V; Murray P
    Br J Cancer; 2001 May; 84(9):1227-34. PubMed ID: 11336475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of cell proliferation index in assessing histological prognostic categories in Hodgkin's disease. An immunohistochemical study with Ki67 and MIB-1 monoclonal antibodies.
    Abele MC; Valente G; Kerim S; Navone R; Onesti P; Chiusa L; Resegotti L; Palestro G
    Haematologica; 1997; 82(3):281-5. PubMed ID: 9234572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute.
    Petera J; Macharová H; Pohanková R; Malír A; Coupek P; Konecný M; Patera J; Pecina J; Drbal J; Koukalová H; Vásová I
    Neoplasma; 2000; 47(2):129-32. PubMed ID: 10985481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.
    Aleman BM; Raemaekers JM; Tomiŝiĉ R; Baaijens MH; Bortolus R; Lybeert ML; van der Maazen RW; Girinsky T; Demeestere G; Lugtenburg P; Lievens Y; de Jong D; Pinna A; Henry-Amar M;
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):19-30. PubMed ID: 17097834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The significance of mediastinal involvement and other risk factors for survival in patients with Hodgkin's disease].
    Melínova L; Hermanská Z; Halíková J; Dienstbier Z; Vacková B; Zámecník J; Skala E
    Vnitr Lek; 1995 May; 41(5):307-12. PubMed ID: 7653060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.